Skip to main content

Table 4 Comparison of haematological parameters at different points in the study. Values are expressed as median (range)

From: A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain

 

Baseline

p*

12 months

p**

24 months

p***

30 months

p****

HCT

0.39(0.33–0.47)

0.008

0.42(0.36–0.47)

0.74

0.42(0.38–0.46)

p <  0.001

0.41 (0.37–0.46)

0.16

RBCs

4.48 (3.66–5.13)

0.008

4.67(3.66–5.13)

0.42

4.77(4.20–5.62)

P <  0.001

4.6 (4.14–5.23)

0.07

Neutrophils

4.8 (2.10–9.50)

0.042

4.1(1.40–6.86)

0.16

3.5(0.31–6.12)

p = 0.007

4.31(3–6.56)

0.18

Monocytes

0.54 (0.20–1.10)

0.009

0.45(0.24–0.70)

0.18

0.46(0.30–0.60)

p = 0.34

0.53 (0.30–0.91)

0.13

  1. p* baseline vs 12 months.
  2. p** 12 months vs 24 months.
  3. p*** baseline vs 24 months.
  4. p**** 24 months vs 30 months.